{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:50:47Z","timestamp":1791345047275,"version":"4.3.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Wuhan Central Hospital Research Fund","award":["23YJ30"],"award-info":[{"award-number":["23YJ30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04481-3","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:06:21Z","timestamp":1783958781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-coated balloon alone versus atherectomy plus drug-coated balloon for treatment of femoropopliteal atherosclerotic disease: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Shao-Bo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Guan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"1","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"e018184","DOI":"10.1136\/bmjopen-2017-018184","volume":"8","author":"L Cea-Soriano","year":"2018","unstructured":"Cea-Soriano L, Fowkes FGR, Johansson S, Allum AM, Garc\u00eda Rodriguez LA. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK. BMJ Open. 2018;8(1):e018184.","journal-title":"BMJ Open"},{"issue":"36","key":"4481_CR2","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700.","journal-title":"Eur Heart J"},{"issue":"9","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.31083\/j.rcm2309315","volume":"23","author":"Q Li","year":"2022","unstructured":"Li Q, Wang L, Zhu L, Wu Y, Wu L, Liu H. Paclitaxel-Coated versus Uncoated Balloon for Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis. Rev Cardiovasc Med. 2022;23(9):315.","journal-title":"Rev Cardiovasc Med"},{"issue":"11","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","volume":"44","author":"D Koeckerling","year":"2023","unstructured":"Koeckerling D, Raguindin PF, Kastrati L, Bernhard S, Barker J, Quiroga Centeno AC, et al. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis. Eur Heart J. 2023;44(11):935\u201350.","journal-title":"Eur Heart J"},{"key":"4481_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2017.08.037","volume":"264","author":"AR Tzafriri","year":"2017","unstructured":"Tzafriri AR, Garcia-Polite F, Zani B, Stanley J, Muraj B, Knutson J, et al. Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis. J Control Release. 2017;264:203\u201310.","journal-title":"J Control Release"},{"issue":"4","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","volume":"37","author":"F Fanelli","year":"2014","unstructured":"Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol. 2014;37(4):898\u2013907.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"4481_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1526602816683933","volume":"24","author":"K Stavroulakis","year":"2016","unstructured":"Stavroulakis K, Schwindt A, Torsello G, Stachmann A, Hericks C, Bosiers MJ, et al. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions. J Endovasc Ther. 2016;24(2):181\u20138.","journal-title":"J Endovasc Ther"},{"key":"4481_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.avsg.2019.06.014","volume":"64","author":"Z Cai","year":"2020","unstructured":"Cai Z, Guo L, Qi L, Cui S, Tong Z, Guo J, et al. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans. Ann Vasc Surg. 2020;64:181\u20137.","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"4481_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/1526602820915244","volume":"27","author":"DG Kokkinidis","year":"2020","unstructured":"Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, et al. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions. J Endovasc Ther. 2020;27(3):492\u2013501.","journal-title":"J Endovasc Ther"},{"key":"4481_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.avsg.2020.10.051","volume":"73","author":"O Rodoplu","year":"2021","unstructured":"Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, et al. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions\u2014Comparison with Sole Drug\u2013coated Balloon Revascularization: Two-year Outcomes. Ann Vasc Surg. 2021;73:222\u201333.","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1526602817748319","volume":"25","author":"K Stavroulakis","year":"2017","unstructured":"Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, et al. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease. J Endovasc Ther. 2017;25(1):92\u20139.","journal-title":"J Endovasc Ther"},{"key":"4481_CR12","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Online). 2021;372:n71\u2013n.","journal-title":"BMJ (Online)"},{"issue":"3","key":"4481_CR13","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12\u20133.","journal-title":"ACP J Club"},{"key":"4481_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"9","key":"4481_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"4481_CR16","doi-asserted-by":"crossref","unstructured":"Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B et al. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency. Circulation: Cardiovascular Interventions. 2017;10(9).","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848"},{"key":"4481_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/VHRM.S371177","volume":"18","author":"NW Shammas","year":"2022","unstructured":"Shammas NW, Purushottam B, Shammas WJ, Christensen L, Shammas G, Weakley D, Jones-Miller S. Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study. Vasc Health Risk Manag. 2022;18:603\u201315.","journal-title":"Vasc Health Risk Manag"},{"key":"4481_CR18","doi-asserted-by":"crossref","unstructured":"Yang L, Quan J, Dong J, Ding N, Han Y, Cong L et al. Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion. Sci Rep. 2024;14(1): 63.","DOI":"10.1038\/s41598-023-50511-8"},{"key":"4481_CR19","doi-asserted-by":"crossref","unstructured":"Cha J-J, Lee J-H, Ko Y-G, Roh J-H, Yoon Y-H, Lee Y-J et al. Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease. Korean Circulation J. 2022;52(2):123-133.","DOI":"10.4070\/kcj.2021.0246"},{"key":"4481_CR20","doi-asserted-by":"crossref","unstructured":"Wischmann P, Stern M, Florea D-I, Neudorf L, Haddad Y, Kramser N et al. Three-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients. Biomedicines. 2024;12(10): 2213.","DOI":"10.3390\/biomedicines12102213"},{"issue":"6","key":"4481_CR21","first-page":"1078","volume":"89","author":"TR Foley","year":"2017","unstructured":"Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ. Mid-term outcomes of orbital atherectomy combined with drug\u2010coated balloon angioplasty for treatment of femoropopliteal disease. Catheter Cardiovasc Interv. 2017;89(6):1078\u201385.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"4481_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Scheinert","year":"2014","unstructured":"Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7(1):10\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"4481_CR23","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00270-022-03265-1","volume":"45","author":"U Teichgr\u00e4ber","year":"2022","unstructured":"Teichgr\u00e4ber U, Lehmann T, Ingwersen M, Aschenbach R, Zeller T, Brechtel K, et al. Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty: 5-Year Results of the Randomized Controlled EffPac Trial. Cardiovasc Intervent Radiol. 2022;45(12):1774\u201383.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"4481_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","volume":"74","author":"Y Xu","year":"2021","unstructured":"Xu Y, Liu J, Zhang J, Zhuang B, Jia X, Fu W, et al. Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial. J Vasc Surg. 2021;74(3):756\u2013e623.","journal-title":"J Vasc Surg"},{"issue":"3","key":"4481_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1708538120953663","volume":"29","author":"G Sun","year":"2021","unstructured":"Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, et al. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study. Vascular. 2021;29(3):340\u20139.","journal-title":"Vascular"},{"issue":"1","key":"4481_CR26","doi-asserted-by":"publisher","first-page":"24260","DOI":"10.1038\/s41598-024-75201-x","volume":"14","author":"DO Kang","year":"2024","unstructured":"Kang DO, Kim S, Kim B, Her A-Y, Shin E-S. Long-term efficacy of drug-coated balloon-based treatment for de novo left anterior descending artery disease. Sci Rep. 2024;14(1):24260.","journal-title":"Sci Rep"},{"issue":"1","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/s41598-025-85734-4","volume":"15","author":"C Gobbi","year":"2025","unstructured":"Gobbi C, Giangiacomi F, Merinopoulos I, Gherbesi E, Faggiano A, Pasero G, et al. Drug coated balloon angioplasty for de novo coronary lesions in large vessels: a systematic review and meta-analysis. Sci Rep. 2025;15(1):4921.","journal-title":"Sci Rep"},{"issue":"4","key":"4481_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/1526602817710770","volume":"24","author":"Y Bausback","year":"2017","unstructured":"Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, et al. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment. J Endovasc Ther. 2017;24(4):459\u201367.","journal-title":"J Endovasc Ther"},{"issue":"12","key":"4481_CR29","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","volume":"14","author":"G Tepe","year":"2021","unstructured":"Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, et al. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv. 2021;14(12):1352\u201361.","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"4481_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","volume":"118","author":"M Werk","year":"2008","unstructured":"Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118(13):1358\u201365.","journal-title":"Circulation"},{"issue":"6","key":"4481_CR31","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","volume":"5","author":"M Werk","year":"2012","unstructured":"Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5(6):831\u201340.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"4481_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/1708538120985732","volume":"29","author":"F Lin","year":"2021","unstructured":"Lin F, Wang H, Ding W, Chen G, Zhang Z. Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis. Vascular. 2021;29(6):883\u201396.","journal-title":"Vascular"},{"key":"4481_CR33","doi-asserted-by":"publisher","first-page":"1184237","DOI":"10.3389\/fcvm.2023.1184237","volume":"10","author":"F Cui","year":"2023","unstructured":"Cui F, Tong Y, Liu G, Zhang W, Liu K, Si D, He Y. Intracoronary imaging-guided rotational atherectomy combined with intravascular lithotripsy in the treatment of severe coronary artery calcification-A case report. Front Cardiovasc Med. 2023;10:1184237.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4481_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/14779072.2022.2069561","volume":"20","author":"R Gardiner","year":"2022","unstructured":"Gardiner R, Muradagha H, Kiernan TJ. Intravascular lithotripsy during percutaneous coronary intervention: current concepts. Expert Rev Cardiovasc Ther. 2022;20(4):323\u201338.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"4481_CR35","first-page":"100436","volume":"1","author":"W Abusnina","year":"2022","unstructured":"Abusnina W, Al-Abdouh A, Radaideh Q, Kanmanthareddy A, Shishehbor MH, White CJ, et al. Atherectomy Plus Balloon Angioplasty for Femoropopliteal Disease Compared to Balloon Angioplasty Alone: A Systematic Review and Meta-analysis. J Soc Cardiovasc Angiogr Interv. 2022;1(6):100436.","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"4481_CR36","first-page":"235","volume":"35","author":"K Deloose","year":"2019","unstructured":"Deloose K, Taeymans K, Callaert O. Endovascular Treatment of No-Stent Zones\u2026 Quo Vadis? Surg Technol Int. 2019;35:235\u201342.","journal-title":"Surg Technol Int"},{"key":"4481_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.avsg.2025.01.019","volume":"114","author":"L Hu","year":"2025","unstructured":"Hu L, Wang H, Pan D, Wu S, Zhang H, Gu Y. Three-Year Results of Combining Debulking Devices with Drug-coated Balloons for the Treatment of De Novo Femoropopliteal Arteriosclerosis Obliterans. Ann Vasc Surg. 2025;114:63\u201373.","journal-title":"Ann Vasc Surg"},{"issue":"17","key":"4481_CR38","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.jcin.2023.06.016","volume":"16","author":"N Okamoto","year":"2023","unstructured":"Okamoto N, Egami Y, Nohara H, Kawanami S, Sugae H, Kawamura A, et al. Direct Comparison of Rotational vs Orbital Atherectomy for Calcified Lesions Guided by Optical Coherence Tomography. JACC Cardiovasc Interv. 2023;16(17):2125\u201336.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"4481_CR39","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00270-025-04063-1","volume":"48","author":"S Kojima","year":"2025","unstructured":"Kojima S, Tokuda T, Tanaka A, Yoshioka N, Yamaguchi K, Yanagiuchi T, et al. One-year Clinical Outcomes and Predictors of Distal Embolization After JETSTREAM\u2122 Atherectomy for Calcified Femoropopliteal Artery Lesions: Results From the JET-FORWARD Study. Cardiovasc Intervent Radiol. 2025;48(6):760\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"4481_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcin.2016.12.014","volume":"10","author":"P Krishnan","year":"2017","unstructured":"Krishnan P, Tarricone A, Purushothaman KR, Purushothaman M, Vasquez M, Kovacic J, et al. An Algorithm for the Use of Embolic Protection During Atherectomy for Femoral Popliteal Lesions. JACC Cardiovasc Interv. 2017;10(4):403\u201310.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"4481_CR41","doi-asserted-by":"publisher","first-page":"e940","DOI":"10.4244\/EIJ-D-21-01098","volume":"18","author":"T Zeller","year":"2022","unstructured":"Zeller T, Brodmann M, Ansel GM, Scheinert D, Choi D, Tepe G, et al. Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study. EuroIntervention. 2022;18(11):e940\u20138.","journal-title":"EuroIntervention"},{"issue":"9","key":"4481_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jcin.2023.03.032","volume":"16","author":"G Tepe","year":"2023","unstructured":"Tepe G, Brodmann M, Micari A, Scheinert D, Choi D, Menk J, Zeller T. 5-Year Outcomes of Drug-Coated Balloons for Peripheral Artery In-Stent Restenosis, Long Lesions, and CTOs. JACC Cardiovasc Interv. 2023;16(9):1065\u201378.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04481-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:14:20Z","timestamp":1791342860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04481-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"736"}}